Marcus Schabacker, President and CEO of ECRI and chair of the board of Institute for Safe Medication Practices (ISMP), speaks with Pharma's Almanac about ways that the healthcare industry can reduce medication errors, and why medical device and drug companies must adapt their approach to support the shift toward more home-based care.
More News
Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue
This news brief appeared in the OR Manager newsletter on September 16, 2021.
ECRI and its affiliate, the Institute for Safe Medication Practices (ISMP), advocate for safe maternal and newborn care; launches site with free resources and safety guidance.